6533b836fe1ef96bd12a195c
RESEARCH PRODUCT
Return of disease activity after natalizumab therapy discontinuation in patients with multiple sclerosis: frequency and clinical and instrumental predictors of reactivation
Sabrina RealmutoGiuseppe SalemiPaolo RagoneseMarianna Lo ReVincenzina Lo ReMaria Antonietta MazzolaGiovanni Savettierisubject
Settore MED/26 - NeurologiaMultiple sclerosis natalizumab therapyyear | journal | country | edition | language |
---|---|---|---|---|
2012-01-01 |